Journals / European Journal of Breast Health / 2022 / Cilt: 18 - Sayı: 2

The Benefit of Routine Axillary Sonographic Assessment in cN0 Breast Cancer Patients

Pages
163–166
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: In the cN0 group the mean value of excised disease-positive axillary lymph nodes was 3.6, while in the cN1 group it was 8.0 (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Axillary ultrasound (US) is often part of the routine assessment of the clinically negative axilla in primary breast cancer, which determines the extent of axillary surgery to be performed.
📊
Key Findings & Data:This study aims to ascertain the burden of disease in the axilla of patients with a normal clinical examination (cN0) but with US detected metastatic axillary lymph nodes.
💡
Conclusion & Impact:Results: In the cN0 group the mean value of excised disease-positive axillary lymph nodes was 3.6, while in the cN1 group it was 8.0 (p
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Axillary ultrasound (US) is often part of the routine assessment of the clinically negative axilla in primary breast cancer, which determines the extent of axillary surgery to be performed. This study aims to ascertain the burden of disease in the axilla of patients with a normal clinical examination (cN0) but with US detected metastatic axillary lymph nodes. Materials and Methods: We retrospectively identified 345 female patients who underwent axillary lymph node dissection, following a positive lymph node biopsy, between January 2015 and August 2019. Eighty-nine of those had a positive biopsy prior to surgery. They were divided into two groups: Those with clinically palpable axillary disease preoperatively, cN1 (n = 41), and those with a normal clinical axillary examination, cN0 (n = 48). We assessed the number of positive axillary lymph nodes dissected in the two groups. Results: In the cN0 group the mean value of excised disease-positive axillary lymph nodes was 3.6, while in the cN1 group it was 8.0 (p

🔖

Cite This Article

SCHNEEBAUM, S., KHATİB, M., SGARDELİS, P., SCHAFFER, O., SUTTON, R. (2022). The Benefit of Routine Axillary Sonographic Assessment in cN0 Breast Cancer Patients. European Journal of Breast Health, Cilt: 18 - Sayı: 2, 163–166. https://ajindex.com/articles/510648

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994
  2. (PMID: 8092905) [Crossref ] 2. Abass MO, Gismalla MDA, Alsheikh AA, Elhassan MMA. Axillary Lymph Node Dissection for Breast Cancer: Efficacy and Complication in Developing Countries. J Glob Oncol 2018
  3. (PMID: 30281378) [Crossref ] 3. Soares EW, Nagai HM, Bredt LC, da Cunha AD Jr, Andrade RJ, Soares GV. Morbidity After Conventional Dissection of Axillary Lymph Nodes in Breast Cancer Patients. World J Surg Oncol 2014
  4. (PMID: 24670000) [Crossref ] 4. I van der Ploeg IM, Nieweg OE, van Rijk MC, Valdés Olmos RA, Kroon BB. Axillary recurrence after a tumor-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol 2008
  5. (PMID: 18406100) [Crossref ] 5. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010
  6. (PMID: 20863759) [Crossref ] 6. Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005
  7. (PMID: 16157938) [Crossref ] 7. Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol 2006
  8. (PMID: 16425290) [Crossref ] 8. Del Bianco P, Zavagno G, Burelli P, Scalco G, Barutta L, Carraro P, et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 2008
  9. (PMID: 17614245) [Crossref ] 9. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003
  10. (PMID: 12904519) [Crossref ] 10. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in